BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25512202)

  • 1. The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
    Martínez-Lapiscina EH; Fraga-Pumar E; Gabilondo I; Martínez-Heras E; Torres-Torres R; Ortiz-Pérez S; Llufriu S; Tercero A; Andorra M; Roca MF; Lampert E; Zubizarreta I; Saiz A; Sanchez-Dalmau B; Villoslada P
    BMC Res Notes; 2014 Dec; 7():910. PubMed ID: 25512202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS.
    Moster S; Wilson JA; Galetta SL; Balcer LJ
    J Neurol Sci; 2014 Aug; 343(1-2):105-9. PubMed ID: 24954088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field impairment captures disease burden in multiple sclerosis.
    Ortiz-Perez S; Andorra M; Sanchez-Dalmau B; Torres-Torres R; Calbet D; Lampert EJ; Alba-Arbalat S; Guerrero-Zamora AM; Zubizarreta I; Sola-Valls N; Llufriu S; Sepúlveda M; Saiz A; Villoslada P; Martinez-Lapiscina EH
    J Neurol; 2016 Apr; 263(4):695-702. PubMed ID: 26860093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients.
    Noble J; Forooghian F; Sproule M; Westall C; O'Connor P
    Am J Ophthalmol; 2006 Sep; 142(3):464-8. PubMed ID: 16935592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
    Blanco R; Pérez-Rico C; Puertas-Muñoz I; Ayuso-Peralta L; Boquete L; Arévalo-Serrano J
    Mult Scler; 2014 Feb; 20(2):183-91. PubMed ID: 23828868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Color vision is strongly associated with retinal thinning in multiple sclerosis.
    Villoslada P; Cuneo A; Gelfand J; Hauser SL; Green A
    Mult Scler; 2012 Jul; 18(7):991-9. PubMed ID: 22291035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis.
    Chahin S; Miller D; Sakai RE; Wilson JA; Frohman T; Markowitz C; Jacobs D; Green A; Calabresi PA; Frohman EM; Galetta SL; Balcer LJ
    Mult Scler Relat Disord; 2015 Jul; 4(4):304-10. PubMed ID: 26195047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
    Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
    Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
    Schinzel J; Zimmermann H; Paul F; Ruprecht K; Hahn K; Brandt AU; Dörr J
    BMC Neurol; 2014 Feb; 14():31. PubMed ID: 24555757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sight-dependent quality of life and ophthalmic findings in a group of Brazilian patients with multiple sclerosis.
    Fragoso YD; Nosé RM; Nosé RA; Nosé W; Vieira S; Finkelsztejn A
    Arq Neuropsiquiatr; 2011 Oct; 69(5):809-13. PubMed ID: 22042186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electropysiologic evaluation of the visual pathway in patients with multiple sclerosis.
    Rodriguez-Mena D; Almarcegui C; Dolz I; Herrero R; Bambo MP; Fernandez J; Pablo LE; Garcia-Martin E
    J Clin Neurophysiol; 2013 Aug; 30(4):376-81. PubMed ID: 23912576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
    Jasse L; Vukusic S; Durand-Dubief F; Vartin C; Piras C; Bernard M; Pélisson D; Confavreux C; Vighetto A; Tilikete C
    Mult Scler; 2013 Oct; 19(12):1618-26. PubMed ID: 23462348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
    Pérez-Rico C; Ayuso-Peralta L; Rubio-Pérez L; Roldán-Díaz I; Arévalo-Serrano J; Jiménez-Jurado D; Blanco R
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6127-31. PubMed ID: 25190654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The visual pathway as a model to understand brain damage in multiple sclerosis.
    Martínez-Lapiscina EH; Sanchez-Dalmau B; Fraga-Pumar E; Ortiz-Perez S; Tercero-Uribe AI; Torres-Torres R; Villoslada P
    Mult Scler; 2014 Nov; 20(13):1678-85. PubMed ID: 25013155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.
    Ekici F; Loh R; Waisbourd M; Sun Y; Martinez P; Nayak N; Wizov SS; Hegarty S; Hark LA; Spaeth GL
    JAMA Ophthalmol; 2015 Dec; 133(12):1377-85. PubMed ID: 26425961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
    Soufi G; AitBenhaddou E; Hajji Z; Tazrout S; Benomar A; Soufi M; Boulanouar A; Abouqal R; Yahyaoui M; Berraho A
    J Fr Ophtalmol; 2015 Jun; 38(6):497-503. PubMed ID: 25896580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
    Morrow SA; Rosehart H; Pantazopoulos K
    J Neuropsychiatry Clin Neurosci; 2016; 28(2):118-23. PubMed ID: 26569152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation.
    Gundogan FC; Demirkaya S; Sobaci G
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5773-81. PubMed ID: 18055831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis, monitoring, and treatment of optic neuritis.
    Chan JW
    Neurologist; 2012 Jan; 18(1):23-31. PubMed ID: 22217611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colour vision impairment is associated with disease severity in multiple sclerosis.
    Martínez-Lapiscina EH; Ortiz-Pérez S; Fraga-Pumar E; Martínez-Heras E; Gabilondo I; Llufriu S; Bullich S; Figueras M; Saiz A; Sánchez-Dalmau B; Villoslada P
    Mult Scler; 2014 Aug; 20(9):1207-16. PubMed ID: 24399824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.